View Post Virologic Effectiveness of Abacavir/Lamivudine with Darunavir/Ritonavir Versus Other Protease Inhibitors in Treatment-Experienced HIV-Infected Patients in Clinical Practice. Clinical Drug Investigation, 37: 51-60. In by AHFJanuary 15, 2017
View Post Telmisartan Increases Vascular Reparative Capacity in Older HIV-Infected Adults: A Pilot Study. HIV Clinical Trials, 17(6): 225-232. In by AHFNovember 15, 2016
View Post HIV-1-Specific Chimeric Antigen Receptors Based on Broadly Neutralizing Antibodies. Journal of Virology, 90(15): 6999-7006. In by AHFAugust 15, 2016
View Post Isoniazid Therapy for Mycobacterium Tuberculosis Infection in HIV Clinics, Los Angeles, California. The International Journal of Tuberculosis and Lung Disease, 20(7): 961-966. In by AHFJuly 15, 2016
View Post Reaching Suburban Men Who Have Sex with Men for STD and HIV Services Through Online Social Networking Outreach. Journal of Acquired Immune Deficiency Syndromes, 72(1): 73-78. In by AHFMay 1, 2016
View Post Supranormal Thymic Output up to 2 Decades after HIV-1 Infection. AIDS, 30: 701-711. In by AHFMarch 15, 2016
View Post The ASSURE Study: HIV-1 Suppression Is Maintained with Bone and Renal Biomarker Improvement 48 Weeks after Ritonavir Discontinuation and Randomized Switch to Abacavir/Lamivudine + Atazanavir. HIV Medicine, 17(2): 106-117. In by AHFFebruary 1, 2016
View Post Gender and HIV Testing Service Uptake: Trend in Northern Nigeria. Journal of AIDS & Clinical Research, 7(12): 1-4. In by AHFJanuary 1, 2016
View Post Will Ebola Change the Game? Ten Essential Reforms Before the Next Pandemic. The Report of the Harvard-LSHTM Independent Panel on the Global Response to Ebola. The Lancet, 386: 2204-2221. In by AHFNovember 15, 2015
View Post Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman Primates. Journal of Virology, 89(16): 8643-8650. In by AHFAugust 15, 2015
